Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Daily News

Women More Likely Than Men to Develop CIN after Angiography

L.A. McKeown

April 29, 2011

Advertisement

September 2024 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

Top Endovascular News of 2023

November 2023 News Roundup

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

BP Reduction With Renal Denervation Still Evident a Decade On

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

November 2021 News Roundup

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Treating Accessory Arteries May Be Important in Renal Denervation

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

TCTMD’s Top 10 Most Popular Stories for May 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Women More Likely Than Men to Develop CIN after Angiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content